Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.

Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, Chen B, Chan J, Braunstein M, Orme IM, Derrick SC, Morris SL, Jacobs WR Jr, Porcelli SA.

J Clin Invest. 2007 Aug;117(8):2279-88.

2.

Who puts the tubercle in tuberculosis?

Russell DG.

Nat Rev Microbiol. 2007 Jan;5(1):39-47. Epub 2006 Dec 11. Review.

PMID:
17160001
3.

Exiting the outside world for cross-presentation.

Rock KL.

Immunity. 2006 Oct;25(4):523-5.

4.

Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.

Kaufmann SH, Baumann S, Nasser Eddine A.

Int J Tuberc Lung Dis. 2006 Oct;10(10):1068-79. Review.

PMID:
17044198
5.

Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection.

Sud D, Bigbee C, Flynn JL, Kirschner DE.

J Immunol. 2006 Apr 1;176(7):4296-314. Erratum in: J Immunol. 2006 Oct 15;177(8):5747.

6.

Lessons from experimental Mycobacterium tuberculosis infections.

Flynn JL.

Microbes Infect. 2006 Apr;8(4):1179-88. Epub 2006 Jan 18. Review.

PMID:
16513383
7.

Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

Winau F, Weber S, Sad S, de Diego J, Hoops SL, Breiden B, Sandhoff K, Brinkmann V, Kaufmann SH, Schaible UE.

Immunity. 2006 Jan;24(1):105-17.

8.

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.

Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Dourado I, Cruz AA, Sant'Anna C, Bierrenbach AL, Barreto ML.

Lancet. 2005 Oct 8;366(9493):1290-5. Epub 2005 Aug 31.

PMID:
16214599
9.

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, Mann P, Goosmann C, Bandermann S, Smith D, Bancroft GJ, Reyrat JM, van Soolingen D, Raupach B, Kaufmann SH.

J Clin Invest. 2005 Sep;115(9):2472-9. Epub 2005 Aug 18.

10.

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV.

Nat Med. 2004 Nov;10(11):1240-4. Epub 2004 Oct 24. Erratum in: Nat Med. 2004 Dec;10(12):1397.

PMID:
15502839
11.

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.

Olsen AW, Williams A, Okkels LM, Hatch G, Andersen P.

Infect Immun. 2004 Oct;72(10):6148-50.

12.

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.

Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, Campos-Neto A, Lobet Y, Dalemans W, Orme IM, Reed SG.

J Immunol. 2004 Jun 15;172(12):7618-28.

13.

Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis.

Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR Jr.

Nat Immunol. 2003 Oct;4(10):949-55. Review.

PMID:
14515128
14.

Human immunity to M. tuberculosis: T cell subsets and antigen processing.

Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M.

Tuberculosis (Edinb). 2003;83(1-3):98-106. Review.

PMID:
12758197
15.

SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis.

Braunstein M, Espinosa BJ, Chan J, Belisle JT, Jacobs WR Jr.

Mol Microbiol. 2003 Apr;48(2):453-64.

17.

Comparative and functional genomics of the Mycobacterium tuberculosis complex.

Cole ST.

Microbiology. 2002 Oct;148(Pt 10):2919-28. Review. No abstract available.

PMID:
12368425
18.

Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.

Ramachandra L, Chu RS, Askew D, Noss EH, Canaday DH, Potter NS, Johnsen A, Krieg AM, Nedrud JG, Boom WH, Harding CV.

Immunol Rev. 1999 Apr;168:217-39. Review.

PMID:
10399077
19.

Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.

Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH.

J Immunol. 1999 Jan 1;162(1):372-9.

20.

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F.

JAMA. 1994 Mar 2;271(9):698-702.

PMID:
8309034

Supplemental Content

Support Center